Research and Markets: Europe Nuclear Medicine Market - Trends And Forecasts 2014-2020

Research and Markets (http://www.researchandmarkets.com/research/prrsk4/europe_nuclear) has announced the addition of the "Europe Nuclear Medicine Market - Trends And Forecasts (2014-2020)" report to their offering.

Europe market for nuclear medicine stood at $1.4 billion in 2014 and is expected to reach approximately $1.9 billion in 2019 with a CAGR of 7.2%

Market for Technetium-99m is expected to increase owing to the rise in cases of cancer and cardiac ailments.

Nuclear medicine has high potential for treatment of neurological diseases like Parkinson's, Alzheimer's and dementia. Practitioners prefer radiopharmaceuticals over conventional methods of treatments in neurological diseases.

Study estimates that Tc-99m diagnostic procedures are expected to increase by 15% to 20% in mature markets such as Europe, and other developed regions between 2010 and 2030.

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Market Overview

4. Market Dynamics

5. Europe Nuclear Medicine Market Segmentation

6. Nuclear Medicine Market, By Type Of Products

7. Diagnostic Market, By Application

8. Others

9. Competitive Landscape

10. Company Profiles

- Bracco Imaging S.P.A.

- Cambridge Isotope Laboratories, Inc.

- Cardinal Health, Inc.

- Covidien, Plc

- Eczacibasi-Monrol

- Fujifilm Holdings Corporation

- Ge Healthcare (Subsidiary Of General Electric Company)

- Iba Group

- Institute Of Radioelement (IRE)

- Isotec, Inc. (Sigma-Aldrich)

- Lantheus Medical Imaging, Inc.

- Nordion, Inc.

For more information visit http://www.researchandmarkets.com/research/prrsk4/europe_nuclear